Bulk Manufacturer of Controlled Substances Application: Curia Wisconsin, Inc., 55041-55042 [2022-19393]
Download as PDF
<![CDATA[
55041
Federal Register / Vol. 87, No. 173 / Thursday, September 8, 2022 / Notices
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 26, 2022, Catalent
CTS, LLC, 10245 Hickman Mills Drive,
Kansas City, Missouri 64137–1418,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
Controlled
substance
Drug code
The company plans to import the
listed controlled substances as dosage
unit products for clinical trial studies.
In reference to drug code 7370
(Tetrahydrocannabinols), the company
plans to import a synthetic
tetrahydrocannabinol. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Kristi O’Malley,
Assistant Administrator.
[FR Doc. 2022–19394 Filed 9–7–22; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1076]
Bulk Manufacturer of Controlled
Substances Application: Curia
Wisconsin, Inc.
Schedule
2010
I
7350
I
7360
7370
I
I
ACTION:
Notice of application.
Curia Wisconsin, Inc., has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before November 7, 2022. Such
persons may also file a written request
for a hearing on the application on or
before November 7, 2022.
DATES:
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on July 25, 2022, Curia
Wisconsin, Inc., 870 Badger Circle,
Grafton, Wisconsin 53024–0000,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug Enforcement
Administration, Justice.
AGENCY:
Gamma Hydroxybutyric Acid.
Marihuana Extract.
Marihuana .........
Tetrahydrocannabinols.
Supplementary Information listed below
for further drug information.
Controlled substance
Drug code
khammond on DSKJM1Z7X2PROD with NOTICES
Lysergic acid diethylamide ..............................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..........................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
Psilocybin .........................................................................................................................................................................
Psilocyn ...........................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Nabilone ...........................................................................................................................................................................
ANPP (4-Anilino-N-phenethyl-4-piperidine) .....................................................................................................................
Fentanyl ...........................................................................................................................................................................
VerDate Sep<11>2014
18:19 Sep 07, 2022
Jkt 256001
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
E:\FR\FM\08SEN1.SGM
08SEN1
7315
7370
7392
7400
7405
7431
7435
7437
7438
1724
7379
8333
9801
Schedule
I
I
I
I
I
I
I
I
I
II
II
II
II
55042
Federal Register / Vol. 87, No. 173 / Thursday, September 8, 2022 / Notices
The company plans to bulk
manufacture the listed controlled
substances for the purpose of analytical
reference standards or for sale to its
customers. In reference to the drug code
7370 (Tetrahydrocannabinols), the
company plans to bulk manufacture as
synthetic. No other activity for this drug
code is authorized for this registration.
Kristi O’Malley,
Assistant Administrator.
[FR Doc. 2022–19393 Filed 9–7–22; 8:45 am]
BILLING CODE P
DEPARTMENT OF LABOR
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request;
Application for Prevailing Wage
Determination
Notice of availability; request
for comments.
ACTION:
The Department of Labor
(DOL) is submitting this Employment
and Training Administration (ETA)sponsored information collection
request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are
invited.
DATES: The OMB will consider all
written comments that the agency
receives on or before October 11, 2022.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Comments are invited on: (1) whether
the collection of information is
necessary for the proper performance of
the functions of the Department,
including whether the information will
have practical utility; (2) if the
information will be processed and used
in a timely manner; (3) the accuracy of
the agency’s estimates of the burden and
cost of the collection of information,
including the validity of the
methodology and assumptions used; (4)
ways to enhance the quality, utility and
clarity of the information collection; and
(5) ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
automated collection techniques or
other forms of information technology.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:19 Sep 07, 2022
Jkt 256001
FOR FURTHER INFORMATION CONTACT:
Mara Blumenthal by telephone at 202–
693–8538, or by email at DOL_PRA_
PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION: The
Immigration and Nationality Act (INA),
as amended, assigns responsibilities to
the Secretary of Labor (Secretary)
relating to the entry and employment of
certain categories of immigrant and
nonimmigrant foreign workers under
the PERM, H–2B, H–1B, H–1B1, and
E–3 programs. The INA requires the
Secretary to certify that the employment
of foreign workers under certain visa
classifications will not adversely affect
the wages and working conditions of
similarly employed workers in the
United States. To render this
certification, the Secretary determines
the prevailing wage for the occupational
classification and area of intended
employment and ensures the employer
offers a wage to the foreign worker that
equals at least the prevailing wage. The
Department uses Forms ETA–9141 and
ETA–9165 to collect information
necessary to determine the prevailing
wage for the applicable occupation and
area of intended employment. For
additional substantive information
about this ICR, see the related notice
published in the Federal Register on
June 14, 2022 (87 FR 35999).
This information collection is subject
to the PRA. A Federal agency generally
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless the OMB
approves it and displays a currently
valid OMB Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information that does not
display a valid OMB Control Number.
See 5 CFR 1320.5(a) and 1320.6.
DOL seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOL notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.
Agency: DOL–ETA.
Title of Collection: Application for
Prevailing Wage Determination.
OMB Control Number: 1205–0508.
Affected Public: Private Sector—
Businesses or other for-profits, not-forprofit institutions, and farms.
Total Estimated Number of
Respondents: 102,418.
Total Estimated Number of
Responses: 331,339.
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
Total Estimated Annual Time Burden:
148,629 hours.
Total Estimated Annual Other Costs
Burden: $213,953.
(Authority: 44 U.S.C. 3507(a)(1)(D))
Dated: September 1, 2022.
Mara Blumenthal,
Senior PRA Analyst.
[FR Doc. 2022–19359 Filed 9–7–22; 8:45 am]
BILLING CODE 4510–FP–P
DEPARTMENT OF LABOR
Mine Safety and Health Administration
Petition for Modification of Application
of Existing Mandatory Safety
Standards
Mine Safety and Health
Administration, Labor.
ACTION: Notice.
AGENCY:
This notice is a summary of
a petition for modification submitted to
the Mine Safety and Health
Administration (MSHA) by the party
listed below.
DATES: All comments on the petition
must be received by MSHA’s Office of
Standards, Regulations, and Variances
on or before October 11, 2022.
ADDRESSES: You may submit comments
identified by Docket No. MSHA–2022–
046 by any of the following methods:
1. Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments
for MSHA–2022–046
2. Fax: 202–693–9441.
3. Email: petitioncomments@dol.gov.
4. Regular Mail or Hand Delivery:
MSHA, Office of Standards,
Regulations, and Variances, 201 12th
Street South, Suite 4E401, Arlington,
Virginia 22202–5452.
Attention: S. Aromie Noe, Director,
Office of Standards, Regulations, and
Variances. Persons delivering
documents are required to check in at
the receptionist’s desk in Suite 4E401.
Individuals may inspect copies of the
petition and comments during normal
business hours at the address listed
above. Before visiting MSHA in person,
call 202–693–9455 to make an
appointment, in keeping with the
Department of Labor’s COVID–19
policy. Special health precautions may
be required.
FOR FURTHER INFORMATION CONTACT: S.
Aromie Noe, Office of Standards,
Regulations, and Variances at 202–693–
9440 (voice), Petitionsformodification@
dol.gov (email), or 202–693–9441 (fax).
[These are not toll-free numbers.]
SUPPLEMENTARY INFORMATION: Section
101(c) of the Federal Mine Safety and
SUMMARY:
E:\FR\FM\08SEN1.SGM
08SEN1
]]>Agencies
[Federal Register Volume 87, Number 173 (Thursday, September 8, 2022)]
[Notices]
[Pages 55041-55042]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19393]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1076]
Bulk Manufacturer of Controlled Substances Application: Curia
Wisconsin, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Curia Wisconsin, Inc., has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
November 7, 2022. Such persons may also file a written request for a
hearing on the application on or before November 7, 2022.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on July 25, 2022, Curia Wisconsin, Inc., 870 Badger
Circle, Grafton, Wisconsin 53024-0000, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide............... 7315 I
Tetrahydrocannabinols.................... 7370 I
4-Bromo-2,5-dimethoxyphenethylamine...... 7392 I
3,4-Methylenedioxyamphetamine............ 7400 I
3,4-Methylenedioxymethamphetamine........ 7405 I
5-Methoxy-N-N-dimethyltryptamine......... 7431 I
Dimethyltryptamine....................... 7435 I
Psilocybin............................... 7437 I
Psilocyn................................. 7438 I
Methylphenidate.......................... 1724 II
Nabilone................................. 7379 II
ANPP (4-Anilino-N-phenethyl-4-piperidine) 8333 II
Fentanyl................................. 9801 II
------------------------------------------------------------------------
[[Page 55042]]
The company plans to bulk manufacture the listed controlled
substances for the purpose of analytical reference standards or for
sale to its customers. In reference to the drug code 7370
(Tetrahydrocannabinols), the company plans to bulk manufacture as
synthetic. No other activity for this drug code is authorized for this
registration.
Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-19393 Filed 9-7-22; 8:45 am]
BILLING CODE P
